Phibro Animal Health (PAHC) Other Non-Current Liabilities (2013 - 2026)
Phibro Animal Health (PAHC) posted quarterly Other Non-Current Liabilities of $1.2 million for Q1 2026, down 89.85% year-over-year from $12.2 million in Q1 2025, and down 88.21% quarter-over-quarter from $10.5 million in Q4 2025.
Phibro Animal Health (PAHC) Other Non-Current Liabilities (2013 - 2026) Analysis & Trends
Phibro Animal Health's Other Non-Current Liabilities history runs 14 years deep, the most recent figure standing at $1.2 million for Q1 2026.
- In Q1 2026, Other Non-Current Liabilities fell 89.85% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (down 89.85% YoY), while the FY2025 annual figure was $79.3 million, up 1058.49% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $1.2 million, down from $10.5 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $79.3 million in Q2 2025, with the low at $1.2 million in Q1 2026.
- The 5-year median for Other Non-Current Liabilities is $9.2 million (2022), against an average of $25.5 million.
- The sharpest annual moves came in 2023 and 2025: Other Non-Current Liabilities plunged 89.96% in 2023, then surged 1119.56% in 2025.
- Phibro Animal Health's Other Non-Current Liabilities stood at $9.2 million in 2022, then slipped by 22.18% to $7.1 million in 2023, then jumped by 65.0% to $11.8 million in 2024, then decreased by 11.05% to $10.5 million in 2025, then sank by 88.21% to $1.2 million in 2026.
- Business Quant data shows PAHC's Other Non-Current Liabilities at $1.2 million in Q1 2026, $10.5 million in Q4 2025, and $79.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Phibro Animal Health | 1.42 Bn | 1.35 Bn | 125.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.24 Mn |
| Dec 31, 2025 | 10.48 Mn |
| Sep 30, 2025 | 79.19 Mn |
| Jun 30, 2025 | 79.31 Mn |
| Mar 31, 2025 | 12.17 Mn |
| Dec 31, 2024 | 11.78 Mn |
| Sep 30, 2024 | 6.49 Mn |
| Jun 30, 2024 | 6.85 Mn |
| Mar 31, 2024 | 63.86 Mn |
| Dec 31, 2023 | 7.14 Mn |
| Sep 30, 2023 | 6.09 Mn |
| Jun 30, 2023 | 6.08 Mn |
| Mar 31, 2023 | 61.78 Mn |
| Dec 31, 2022 | 9.17 Mn |
| Sep 30, 2022 | 5.92 Mn |
| Jun 30, 2022 | 60.50 Mn |
| Mar 31, 2022 | 5.73 Mn |
| Dec 31, 2021 | 55.72 Mn |
| Sep 30, 2021 | 56.14 Mn |
| Jun 30, 2021 | 55.97 Mn |